abstract:An open-label trial or open trial is a type of clinical trial in which both the researchers and participants know which treatment is being administered.
Inthesafety study, a 52-week open-labeltrial, Dr.Wortzman andcolleaguesreportedclindamycin-tretinoingel to be safe and well tolerated in 655 patients (meanage, 20years).
Obviously, an unblinded trial design (also known as an open-label trial) represents a particularly high-risk approach when the outcome involves a subjective assessment by either the patient or the physician.